These include consideration of the underlying patient population being tested, as well as the possibly significant clinical and public health implications of missed COVID-19 cases.
← all excerpts
Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2.
1
—
—